<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_integrating" title="Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus" shortTitle="integrating" author="Robin D.V. Kleinert, Eduardo Montoya-Diaz, Tanvi Khera, Kathrin Welsch, Birthe Tegtmeyer, Sebastian Hoehl, Sandra Ciesek, Richard J.P. Brown" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1999-4915/11/10/960/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
5.	LS	5.
Tropism	NNP	Tropism
of	IN	of
YFV	NNP	YFV
</s>
</head>
<p>
<s type="decl">
In	IN	in
humans	NNS	human
,	,	,
after	IN	after
transcutaneous	JJ	transcutaneous
inoculation	NN	inoculation
,	,	,
YFV	NNP	YFV
exhibits	VBZ	exhibit
broad	JJ	broad
patterns	NNS	pattern
of	IN	of
tissue	NN	tissue
tropism	NN	tropism
and	CC	and
is	VBZ	be
disseminated	VBN	disseminate
systemically	RB	systemically
via	IN	via
infection	NN	infection
of	IN	of
multiple	JJ	multiple
white	JJ	white
cell	NN	cell
subsets	NNS	subset
.	.	.
</s>
<s type="decl">
With	IN	with
respect	NN	respect
to	IN	to
organ	NN	organ
tropism	NN	tropism
,	,	,
the	DT	the
liver	NN	liver
is	VBZ	be
the	DT	the
primary	JJ	primary
target	NN	target
,	,	,
although	IN	although
the	DT	the
heart	NN	heart
,	,	,
kidneys	NNS	kidney
,	,	,
liver	NN	liver
,	,	,
spleen	NN	spleen
,	,	,
and	CC	and
less	RBR	less
frequently	RB	frequently
,	,	,
the	DT	the
brain	NN	brain
tissue	NN	tissue
,	,	,
can	MD	can
support	VB	support
YFV	NN	YFV
replication	NN	replication
.	.	.
</s>
<s type="decl">
The	DT	the
natural	JJ	natural
host	NN	host
range	NN	range
of	IN	of
YFV	NNP	YFV
includes	VBZ	include
humans	NNS	human
,	,	,
non-human	JJ	non-human
primates	NNS	primate
and	CC	and
mosquitos	NNS	mosquito
.	.	.
</s>
<s type="decl">
Additionally	RB	additionally
,	,	,
wild	JJ	wild
animals	NNS	animal
from	IN	from
the	DT	the
diverse	JJ	diverse
orders	NNS	order
Artiodactyla	NNP	Artiodactyla
,	,	,
Carnivora	NNP	Carnivora
and	CC	and
the	DT	the
superorder	NN	superorder
Xenarthra	NNP	Xenarthra
have	VBP	have
been	VBN	be
reported	VBN	report
to	TO	to
be	VB	be
serologically	RB	serologically
positive	JJ	positive
for	IN	for
anti-YFV	JJ	anti-YFV
antibodies	NNS	antibody
,	,	,
and	CC	and
the	DT	the
elicitation	NN	elicitation
of	IN	of
antibody	NN	antibody
responses	NNS	response
against	IN	against
YFV	NNP	YFV
indicates	VBZ	indicate
a	DT	a
potentially	RB	potentially
productive	JJ	productive
infection	NN	infection
within	IN	within
these	DT	this
species	NNS	species
,	,	,
indicating	VBG	indicate
that	IN	that
diverse	JJ	diverse
mammalian	JJ	mammalian
species	NNS	species
could	MD	could
represent	VB	represent
YFV	NNP	YFV
potential	JJ	potential
reservoirs	NNS	reservoir
(	-LRB-	(
see	VB	see
Section	NN	section
8.3	CD	8.3
)	-RRB-	)
.	.	.
</s>
</p>
<head>
<s type="frag">
Mouse	NNP	Mouse
Models	NNS	model
for	IN	for
YFV	NNP	YFV
</s>
</head>
<p>
<s type="decl">
YFV	NNP	YFV
research	NN	research
is	VBZ	be
currently	RB	currently
limited	VBN	limit
as	IN	as
it	PRP	it
remains	VBZ	remain
challenging	JJ	challenging
and	CC	and
expensive	JJ	expensive
to	TO	to
establish	VB	establish
workflows	NNS	workflow
with	IN	with
non-human	JJ	non-human
primates	NNS	primate
.	.	.
</s>
<s type="decl">
While	IN	while
YFV	NNP	YFV
has	VBZ	have
a	DT	a
limited	JJ	limited
host	NN	host
species-tropism	NN	species-tropism
,	,	,
artificial	JJ	artificial
infection	NN	infection
of	IN	of
laboratory	NN	laboratory
mice	NNS	mouse
and	CC	and
hamsters	NNS	hamster
is	VBZ	be
possible	JJ	possible
,	,	,
although	IN	although
the	DT	the
course	NN	course
of	IN	of
disease	NN	disease
differs	VBZ	differ
from	IN	from
that	DT	that
observed	VBN	observe
in	IN	in
humans	NNS	human
.	.	.
</s>
<s type="decl">
Nevertheless	RB	nevertheless
,	,	,
a	DT	a
number	NN	number
of	IN	of
studies	NNS	study
in	IN	in
genetically	RB	genetically
modified	VBN	modify
or	CC	or
humanized	VBN	humanize
mice	NNS	mouse
have	VBP	have
yielded	VBN	yield
insights	NNS	insight
into	IN	into
YFV	NNP	YFV
infection	NN	infection
and	CC	and
dissemination	NN	dissemination
in	IN	in
vivo	NN	vivo
.	.	.
</s>
<s type="decl">
Single	JJ	single
cell-tracking	NN	cell-tracking
of	IN	of
YFV-17D	NN	yfv-17d
dissemination	NN	dissemination
in	IN	in
different	JJ	different
mouse	NN	mouse
models	NNS	model
identified	VBD	identify
novel	NN	novel
YFV	NNP	YFV
replication	NN	replication
reservoirs	NNS	reservoir
in	IN	in
secondary	JJ	secondary
lymphoid	JJ	lymphoid
compartments	NNS	compartment
,	,	,
with	IN	with
hematopoietic	JJ	hematopoietic
STAT1	NNP	STAT1
knockout	NN	knockout
increasing	VBG	increase
virus-induced	JJ	virus-induced
pathogenicity	NN	pathogenicity
.	.	.
</s>
<s type="decl">
Double-humanized	JJ	Double-humanized
mice	NNS	mouse
have	VBP	have
been	VBN	be
developed	VBN	develop
,	,	,
possessing	VBG	possess
both	CC	both
human	JJ	human
immune	JJ	immune
systems	NNS	system
and	CC	and
hepatocytes	NNS	hepatocyte
,	,	,
and	CC	and
these	DT	this
animals	NNS	animal
represent	VBP	represent
ideal	JJ	ideal
tools	NNS	tool
for	IN	for
monitoring	VBG	monitor
systemic	JJ	systemic
YFV	NN	YFV
infection	NN	infection
in	IN	in
vivo	NN	vivo
as	IN	as
both	DT	both
compartments	NNS	compartment
are	VBP	be
permissive	JJ	permissive
for	IN	for
YFV	NNP	YFV
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
to	IN	to
hepatotropism	NN	hepatotropism
,	,	,
YFV	NNP	YFV
can	MD	can
also	RB	also
be	VB	be
neurotropic	JJ	neurotropic
in	IN	in
rodents	NNS	rodent
,	,	,
primates	NNS	primate
and	CC	and
humans	NNS	human
.	.	.
</s>
<s type="decl">
In	IN	in
contrast	NN	contrast
to	IN	to
polio	NN	polio
virus	NN	virus
and	CC	and
reovirus	NN	reovirus
,	,	,
which	WDT	which
infect	VBP	infect
the	DT	the
brain	NN	brain
via	IN	via
the	DT	the
CNS	NNP	CNS
,	,	,
YFV-17D	NNP	YFV-17D
infects	VBZ	infect
brain	NN	brain
tissue	NN	tissue
by	IN	by
crossing	VBG	cross
the	DT	the
blood-brain	JJ	blood-brain
barrier	NN	barrier
.	.	.
</s>
<s type="decl">
A	DT	a
mouse-neurovirulent	JJ	mouse-neurovirulent
strain	NN	strain
(	-LRB-	(
SPYF	NNP	SPYF
)	-RRB-	)
based	VBN	base
on	IN	on
the	DT	the
Porterfield	NNP	Porterfield
17D	CD	17D
(	-LRB-	(
PYF17D	NNP	PYF17D
)	-RRB-	)
strain	NN	strain
was	VBD	be
derived	VBN	derive
by	IN	by
additional	JJ	additional
passaging	NN	passaging
in	IN	in
SCID	NNP	SCID
mice	NNS	mouse
,	,	,
exhibiting	VBG	exhibit
enhanced	VBN	enhance
neurovirulence	NN	neurovirulence
and	CC	and
neuroinvasiveness	NN	neuroinvasiveness
.	.	.
</s>
<s type="decl">
This	DT	this
enhanced	VBN	enhance
neurotopism	NN	neurotopism
was	VBD	be
correlated	VBN	correlate
with	IN	with
13	CD	13
amino	NN	amino
acid	NN	acid
substitutions	NNS	substitution
,	,	,
five	CD	5
of	IN	of
which	WDT	which
were	VBD	be
located	VBN	locate
in	IN	in
the	DT	the
E	NN	E
protein	NN	protein
.	.	.
</s>
<s type="decl">
Arboviruses	NNS	arboviruse
can	MD	can
encounter	VB	encounter
dissemination	NN	dissemination
barriers	NNS	barrier
in	IN	in
mosquitos	NNS	mosquito
,	,	,
restricting	VBG	restrict
the	DT	the
spreading	NN	spreading
of	IN	of
the	DT	the
virus	NN	virus
within	IN	within
the	DT	the
vector	NN	vector
species	NN	species
.	.	.
</s>
<s type="decl">
These	DT	this
include	VBP	include
innate	JJ	innate
immunity	NN	immunity
related	JJ	related
pathways	NNS	pathway
as	RB	as
well	RB	well
as	IN	as
physical	JJ	physical
tissue	NN	tissue
barriers	NNS	barrier
associated	VBN	associate
with	IN	with
the	DT	the
midgut	NN	midgut
and	CC	and
salivary	JJ	salivary
glands	NNS	gland
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
while	IN	while
patterns	NNS	pattern
of	IN	of
YFV-17D	NN	yfv-17d
dissemination	NN	dissemination
in	IN	in
immunocompetent	JJ	immunocompetent
mice	NNS	mouse
were	VBD	be
restricted	VBN	restrict
,	,	,
infection	NN	infection
of	IN	of
<hi rend="italic">
IFNAR	NNP	IFNAR
</hi>
knockout	NN	knockout
mice	NNS	mouse
resulted	VBD	result
in	IN	in
broad	JJ	broad
dissemination	NN	dissemination
preceding	VBG	precede
viral	JJ	viral
clearance	NN	clearance
,	,	,
indicating	VBG	indicate
that	IN	that
no	DT	no
barriers	NNS	barrier
to	IN	to
dissemination	NN	dissemination
exist	VBP	exist
in	IN	in
the	DT	the
absence	NN	absence
of	IN	of
type	NN	type
I	NNP	I
IFN	NNP	IFN
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
while	IN	while
I	CD	I
and	CC	and
II	CD	II
type	NN	type
IFNs	NNS	IFNS
contribute	VBP	contribute
to	IN	to
control	NN	control
of	IN	of
YFV-17D	NN	yfv-17d
infection	NN	infection
,	,	,
type	NN	type
III	CD	III
IFN	NNP	IFN
was	VBD	be
demonstrated	VBN	demonstrate
to	TO	to
have	VB	have
immunomodulatory	JJ	immunomodulatory
functions	NNS	function
and	CC	and
was	VBD	be
protective	JJ	protective
against	IN	against
YFV-17D	NN	yfv-17d
neuroinvasion	NN	neuroinvasion
in	IN	in
mouse	NN	mouse
models	NNS	model
.	.	.
</s>
<s type="decl">
YFD-17D	NN	yfd-17d
infection	NN	infection
of	IN	of
IFN-α/β	NNP	IFN-α/β
receptor	NN	receptor
and	CC	and
STAT1	NN	STAT1
signaling	NN	signaling
molecule	NN	molecule
deficient	JJ	deficient
mice	NNS	mouse
resulted	VBD	result
in	IN	in
systemic	JJ	systemic
viscerotropic	JJ	viscerotropic
infection	NN	infection
:	:	:
a	DT	a
course	NN	course
of	IN	of
disease	NN	disease
which	WDT	which
resembles	VBZ	resemble
that	DT	that
observed	VBN	observe
in	IN	in
humans	NNS	human
rather	RB	rather
than	IN	than
the	DT	the
typical	JJ	typical
encephalitic	JJ	encephalitic
disease	NN	disease
course	NN	course
commonly	RB	commonly
reported	VBN	report
for	IN	for
mice	NNS	mouse
.	.	.
</s>
<s type="decl">
Finally	RB	finally
,	,	,
while	IN	while
many	JJ	many
flaviviruses	NNS	flaviviruse
share	VBP	share
the	DT	the
common	JJ	common
ability	NN	ability
to	TO	to
antagonize	VB	antagonize
IFN	NNP	IFN
signaling	NN	signaling
and	CC	and
therefore	RB	therefore
enhance	VB	enhance
viral	JJ	viral
replication	NN	replication
,	,	,
the	DT	the
YFV	NNP	YFV
NS5	NNP	NS5
is	VBZ	be
unable	JJ	unable
to	TO	to
bind	VB	bind
murine	NN	murine
STAT2	NNP	STAT2
and	CC	and
in	IN	in
contrast	NN	contrast
to	IN	to
ZIKV	NNP	ZIKV
and	CC	and
DENV	NNP	Denvard
,	,	,
is	VBZ	be
unable	JJ	unable
to	TO	to
engage	VB	engage
human	JJ	human
STAT2	NNP	STAT2
in	IN	in
murine	NN	murine
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Murine	NNP	Murine
STAT2	NNP	STAT2
was	VBD	be
demonstrated	VBN	demonstrate
to	TO	to
repress	VB	repress
YFV	NNP	YFV
replication	NN	replication
in	IN	in
murine	NN	murine
cells	NNS	cell
,	,	,
which	WDT	which
was	VBD	be
correlated	VBN	correlate
with	IN	with
an	DT	a
absence	NN	absence
of	IN	of
IFN-α/β-mediated	NNP	IFN-α/β-mediated
NS5	NNP	NS5
ubiquitination	NN	ubiquitination
.	.	.
</s>
<s type="decl">
Together	RB	together
,	,	,
these	DT	this
mouse	NN	mouse
studies	NNS	study
enhance	VBP	enhance
our	PRP$	our
understanding	NN	understanding
of	IN	of
YFV	NNP	YFV
dissemination	NN	dissemination
and	CC	and
host	NN	host
control	NN	control
in	IN	in
vivo	NN	vivo
.	.	.
</s>
<s type="decl">
These	DT	this
findings	NNS	finding
are	VBP	be
useful	JJ	useful
for	IN	for
the	DT	the
development	NN	development
of	IN	of
the	DT	the
next	JJ	next
generation	NN	generation
of	IN	of
small	JJ	small
animal	NN	animal
disease	NN	disease
models	NNS	model
for	IN	for
YFV	NNP	YFV
,	,	,
which	WDT	which
should	MD	should
endeavor	VB	endeavor
to	TO	to
recapitulate	VB	recapitulate
the	DT	the
disease	NN	disease
course	NN	course
seen	VBN	see
in	IN	in
humans	NNS	human
.	.	.
</s>
<s type="sub">
Thus	RB	thus
,	,	,
the	DT	the
generation	NN	generation
of	IN	of
an	DT	a
immunocompetent	JJ	immunocompetent
mouse	NN	mouse
model	NN	model
would	MD	would
be	VB	be
beneficial	JJ	beneficial
,	,	,
which	WDT	which
could	MD	could
be	VB	be
realized	VBN	realize
by	IN	by
knocking	VBG	knock
out	RP	out
downstream	JJ	downstream
specific	JJ	specific
anti-YFV	JJ	anti-YFV
effectors	NNS	effector
that	WDT	that
directly	RB	directly
inhibit	VBP	inhibit
differential	JJ	differential
aspects	NNS	aspect
of	IN	of
the	DT	the
YFV	NNP	YFV
lifecycle	NN	lifecycle
,	,	,
rather	RB	rather
than	IN	than
upstream	JJ	upstream
master-regulators	NNS	master-regulator
of	IN	of
the	DT	the
antiviral	JJ	antiviral
response	NN	response
.	.	.
</s>
<s type="sub">
Screening	VBG	screen
approaches	NNS	approach
could	MD	could
identify	VB	identify
such	JJ	such
factors	NNS	factor
.	.	.
</s>
</p>
</text>